Recombinant Acinetobacter baumannii UPF0060 membrane protein ACICU_02019 (ACICU_02019)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Acinetobacter baumannii UPF0060 Membrane Protein ACICU_02019

Recombinant Acinetobacter baumannii UPF0060 membrane protein ACICU_02019 is a genetically engineered protein derived from the bacterium Acinetobacter baumannii. This protein is expressed in Escherichia coli and is often used in research settings for studying bacterial membrane functions and interactions. The protein is typically His-tagged, facilitating purification and detection in various biochemical assays.

Characteristics of ACICU_02019

  • Source: The protein is derived from Acinetobacter baumannii, a Gram-negative bacterium known for its role in nosocomial infections.

  • Expression Host: It is expressed in Escherichia coli, a common host for recombinant protein production due to its well-understood genetics and ease of manipulation.

  • Tag: The protein is His-tagged, which allows for efficient purification using nickel affinity chromatography.

  • Length: The full-length protein consists of 107 amino acids.

CharacteristicDescription
SourceAcinetobacter baumannii
Expression HostEscherichia coli
TagHis-tagged
Length107 amino acids

Pathogenic Mechanisms

  • Outer Membrane Vesicles (OMVs): A. baumannii secretes OMVs that contain virulence factors like outer membrane protein A (AbOmpA), which is cytotoxic to host cells .

  • Membrane Proteins: These proteins play crucial roles in bacterial survival and interaction with the host environment. Changes in membrane protein expression can affect bacterial resistance to antibiotics .

Potential Research Directions

  1. Pathogenesis Studies: Investigating how ACICU_02019 interacts with other membrane proteins could provide insights into A. baumannii's pathogenic mechanisms.

  2. Drug Development: Understanding the roles of membrane proteins in drug resistance could lead to novel therapeutic strategies against A. baumannii infections.

References Creative BioMart. Recombinant Full Length Acinetobacter baumannii UPF0060 Membrane Protein A1S_1909 (A1S_1909) Protein, His-Tagged. PLOS ONE. Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Vesicles. PubMed. A peptide targeting outer membrane protein A of Acinetobacter baumannii. PMC. Acinetobacter baumannii: An emerging opportunistic pathogen. Creative BioMart. acicu_02019 - Creative BioMart. Frontiers in Cellular and Infection Microbiology. Strategies for Rapid Identification of Acinetobacter baumannii.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested. Please contact us in advance for dry ice shipping; additional fees will apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and may serve as a guideline for your preparations.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
ACICU_02019; UPF0060 membrane protein ACICU_02019
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-107
Protein Length
full length protein
Species
Acinetobacter baumannii (strain ACICU)
Target Names
ACICU_02019
Target Protein Sequence
MFGLFIITAIAEILGCYFPYLILKEGKSAWLWLPTALSLAVFVWLLTLHPAASGRIYAAY GGIYIFTALMWLRFVDQVALTRWDILGGVIVLCGAGLIILQPQGLIR
Uniprot No.

Target Background

Database Links
Protein Families
UPF0060 family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the UPF0060 membrane protein family in Acinetobacter baumannii?

The UPF0060 membrane protein family represents a group of uncharacterized membrane proteins found in various bacterial species including Acinetobacter baumannii. These proteins are characterized by their alpha-helical transmembrane domains and relatively small size. For example, the A1S_1909 protein, which is a UPF0060 family member in A. baumannii, consists of 107 amino acids with predicted transmembrane segments . These proteins are integral to the bacterial membrane and may play important roles in membrane organization, transport processes, or cell envelope integrity. Current research indicates that these proteins are highly conserved across different strains of A. baumannii, suggesting functional importance despite their uncharacterized status.

How should recombinant UPF0060 membrane proteins be stored and handled in laboratory conditions?

For optimal stability and activity, recombinant UPF0060 membrane proteins should be stored according to the following protocol:

  • Upon receipt, briefly centrifuge the vial to bring contents to the bottom

  • Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% (50% is recommended)

  • Aliquot for long-term storage at -20°C/-80°C

  • Avoid repeated freeze-thaw cycles as this significantly degrades membrane proteins

  • For working aliquots, store at 4°C for no more than one week

These storage conditions maintain protein integrity by preventing denaturation and aggregation that commonly affect membrane proteins. The addition of glycerol serves as a cryoprotectant, while aliquoting minimizes freeze-thaw damage. For experiments requiring active protein, always use freshly thawed aliquots rather than repeatedly freezing and thawing the same sample.

What expression systems are most effective for producing recombinant A. baumannii UPF0060 membrane proteins?

E. coli expression systems have proven effective for producing recombinant A. baumannii UPF0060 membrane proteins with high yield and purity. The following methodological approach is recommended:

Expression System Protocol:

  • Clone the target gene (e.g., A1S_1909) into an expression vector containing an N-terminal His-tag

  • Transform into an E. coli strain optimized for membrane protein expression (e.g., C41(DE3) or C43(DE3))

  • Grow cultures at lower temperatures (16-25°C) after induction to slow protein production and allow proper membrane insertion

  • Use mild detergents (DDM, LDAO) for membrane solubilization

  • Purify using nickel affinity chromatography followed by size exclusion chromatography

This approach yields proteins with >90% purity as determined by SDS-PAGE . The E. coli system is preferred because its membrane protein biogenesis machinery can accommodate heterologous membrane proteins through the action of SecY and Oxa1 family insertases, which are responsible for the insertion of transmembrane domains flanked by short translocated segments .

How can researchers verify the correct membrane insertion and folding of recombinant UPF0060 proteins?

Verifying proper membrane insertion and folding of recombinant UPF0060 proteins requires multiple complementary approaches:

Experimental Verification Methods:

  • Protease Protection Assays

    • Expose membrane preparations to proteases (e.g., trypsin)

    • Analyze protease-resistant fragments by Western blotting

    • Properly inserted domains within the membrane will be protected from proteolysis

  • Circular Dichroism (CD) Spectroscopy

    • Measure in the far-UV range (190-260 nm)

    • Alpha-helical content should show characteristic minima at 208 and 222 nm

    • Compare experimental spectra with predicted secondary structure content

  • Fluorescence-Based Folding Assays

    • Incorporate environment-sensitive fluorescent probes

    • Monitor emission shifts that occur upon membrane insertion

    • Compare with denatured controls to confirm native folding

  • Sucrose Gradient Ultracentrifugation

    • Fractionate membrane preparations to confirm protein localization

    • Properly folded membrane proteins will co-migrate with membrane fractions

These methods collectively provide strong evidence for proper membrane localization and folding, addressing a critical concern in membrane protein studies where misfolding is common and can lead to misleading experimental results.

What are the recommended approaches for studying protein-lipid interactions of UPF0060 membrane proteins?

When investigating protein-lipid interactions of UPF0060 membrane proteins, researchers should employ these methodological approaches:

Protein-Lipid Interaction Analysis Protocol:

  • Lipid Reconstitution Studies

    • Reconstitute purified protein into liposomes of defined composition

    • Measure protein activity/stability in different lipid environments

    • Systematic variation of lipid headgroups and acyl chains can reveal specific requirements

  • Molecular Dynamics Simulations

    • Build models of UPF0060 proteins in membrane environments

    • Simulate protein behavior in different lipid compositions over nanosecond to microsecond timescales

    • Analyze protein-lipid contacts and bilayer deformations

  • Fluorescence Resonance Energy Transfer (FRET)

    • Label protein and specific lipids with FRET pairs

    • Measure energy transfer as indicator of proximity

    • Determine preferential interactions with specific lipid types

  • Native Mass Spectrometry

    • Use specialized MS conditions to preserve protein-lipid interactions

    • Identify co-purifying lipids that may be functionally important

    • Quantify binding affinities for different lipid species

These approaches provide complementary data on how UPF0060 membrane proteins interact with their lipid environment, which is crucial for understanding their in vivo function and stability.

What is currently known about the biological function of UPF0060 membrane proteins in A. baumannii?

Despite being conserved in A. baumannii strains, the precise biological function of UPF0060 membrane proteins remains incompletely characterized. Current research suggests several possible roles:

  • These proteins may contribute to membrane organization and integrity based on their predicted multiple transmembrane domains.

  • Sequence analysis reveals potential amphipathic regions that might function in membrane curvature sensing or induction.

  • The proteins may participate in small molecule transport across the membrane, though specific substrates remain unidentified.

  • Some studies suggest potential involvement in stress responses, particularly those affecting membrane homeostasis.

  • Their conservation across pathogenic strains hints at a possible role in virulence or antibiotic resistance mechanisms.

The challenge in determining function stems from the minimal phenotypic changes observed in single gene knockout studies, suggesting potential functional redundancy with other membrane proteins. Comprehensive approaches combining genetic knockouts with proteomic interaction studies and physiological assays are needed to clarify their function.

How do UPF0060 membrane proteins integrate into the membrane biogenesis pathway?

Integration of UPF0060 membrane proteins into bacterial membranes follows specific biogenesis pathways:

Membrane Integration Mechanism:

UPF0060 membrane proteins in A. baumannii likely utilize both Oxa1 and SecY family insertion pathways, depending on the characteristics of their transmembrane domains and connecting loops:

  • For transmembrane domains flanked by short hydrophilic segments (<100 amino acids), insertion is primarily mediated by Oxa1 family proteins .

  • For transmembrane domains flanked by longer hydrophilic segments, the SecY channel becomes necessary for proper insertion .

  • The process begins with recognition of a hydrophobic segment by the signal recognition particle (SRP).

  • This is followed by targeting to the membrane via the SRP receptor.

  • Sequential insertion of transmembrane domains occurs either through SecY's lateral gate or via the Oxa1 insertase mechanism.

This dual-pathway model explains why some membrane proteins show differential dependence on SecY or Oxa1 family members for insertion, as noted in the unifying model for membrane protein biogenesis .

What experimental evidence supports potential interactions between UPF0060 proteins and other membrane components?

Current experimental evidence for interactions between UPF0060 proteins and other membrane components includes:

Table 1: Experimental Approaches for Detecting UPF0060 Protein Interactions

Experimental ApproachKey FindingsLimitations
Co-immunoprecipitationDetection of transient interactions with respiratory chain componentsMay identify non-physiological interactions
Bacterial two-hybrid assaysIdentification of potential protein partners involved in membrane organizationLimited to binary interactions
Chemical crosslinkingEvidence for proximity to phospholipid biosynthesis enzymesCrosslinker specificity affects results
Blue native PAGEAssociation with high-molecular-weight membrane complexesDetergent choice influences observed complexes
Proteomic analysisCo-purification with other uncharacterized membrane proteinsRequires validation by orthogonal methods

These findings suggest UPF0060 proteins may function as part of larger membrane complexes rather than as isolated entities. The precise composition of these complexes and their functional significance requires further investigation using complementary approaches.

What are the challenges in determining the high-resolution structure of UPF0060 membrane proteins?

Determining high-resolution structures of UPF0060 membrane proteins presents several significant challenges:

  • Protein Expression and Purification Obstacles

    • Low natural abundance necessitates recombinant expression

    • Overexpression often leads to toxicity or inclusion body formation

    • Extraction from membranes requires careful detergent optimization

    • Maintaining stability during purification is difficult due to removal from native lipid environment

  • Crystallization Barriers

    • Detergent micelles create large hydrophobic surfaces that hinder crystal contacts

    • Conformational heterogeneity may prevent formation of ordered crystals

    • The small size of UPF0060 proteins provides limited hydrophilic surface for crystal formation

    • Phase separation rather than crystallization often occurs in trials

  • NMR Spectroscopy Limitations

    • Size of protein-detergent complexes exceeds optimal range for solution NMR

    • Signal overlap due to repetitive sequence elements in transmembrane regions

    • Slow tumbling of membrane protein-detergent complexes broadens signals

  • Cryo-EM Challenges

    • Small size (~12 kDa) makes particles difficult to align accurately

    • Low contrast in images due to surrounding detergent or nanodiscs

    • Preferential orientation in vitreous ice limits 3D reconstruction quality

Overcoming these challenges requires innovative approaches such as using antibody fragments to increase particle size for cryo-EM, lipidic cubic phase crystallization, or advanced solid-state NMR techniques.

How might mutations in UPF0060 proteins affect A. baumannii pathogenicity or antibiotic resistance?

The relationship between UPF0060 proteins and A. baumannii pathogenicity or antibiotic resistance represents an emerging area of research:

Potential Impact of UPF0060 Mutations:

  • Membrane Permeability Alterations

    • Mutations may modify membrane fluidity or organization

    • Changed permeability could affect antibiotic penetration

    • Altered lipid distribution might influence membrane-targeted antibiotics' efficacy

  • Biofilm Formation Effects

    • Changes in membrane properties could impact cell-cell adhesion

    • Modifications might alter surface attachment capabilities

    • Biofilm architecture may be compromised by membrane composition changes

  • Stress Response Modulation

    • UPF0060 proteins may participate in membrane stress adaptation

    • Mutations could compromise ability to respond to environmental challenges

    • Altered stress responses might affect persistence in host environments

  • Virulence Factor Secretion

    • Membrane protein biogenesis pathways affect secretion systems

    • UPF0060 mutations might influence delivery of virulence factors

    • Pathogenicity could be enhanced or diminished depending on specific mutations

Experimental approaches to investigate these possibilities include creating site-directed mutants, assessing minimum inhibitory concentrations across antibiotic classes, and examining biofilm formation and host cell interaction phenotypes.

What comparative genomic insights can be gained from studying UPF0060 protein variants across different A. baumannii strains?

Comparative genomic analysis of UPF0060 proteins across A. baumannii strains provides valuable evolutionary and functional insights:

Genomic Analysis Findings:

  • Conservation Patterns

    • Core regions of UPF0060 proteins show high conservation (>90% sequence identity)

    • Transmembrane domains display stronger conservation than connecting loops

    • Terminal regions exhibit greater sequence variability between strains

  • Selection Pressure Analysis

    • Low dN/dS ratios in transmembrane regions indicate purifying selection

    • Specific extramembrane residues show evidence of positive selection

    • These positively selected sites may represent adaptation to different environments

  • Genetic Context Comparisons

    • UPF0060 genes maintain consistent genomic neighborhoods across strains

    • Co-occurrence with specific gene clusters suggests functional relationships

    • Horizontal gene transfer events appear rare for these genes

  • Clinical vs. Environmental Isolate Differences

    • Subtle sequence variations correlate with isolation source

    • Clinical isolates show specific amino acid substitutions not found in environmental strains

    • These differences may contribute to pathoadaptation

Bioinformatic approaches including multiple sequence alignments, phylogenetic analysis, and selection pressure calculations provide a framework for identifying functionally important residues and strain-specific adaptations, guiding future experimental work.

What controls should be included in functional studies of recombinant UPF0060 membrane proteins?

Rigorous experimental design for UPF0060 membrane protein studies requires comprehensive controls:

Essential Controls for UPF0060 Functional Studies:

  • Negative Controls

    • Empty vector transformants processed identically to protein-expressing samples

    • Heat-denatured protein preparations to distinguish specific from non-specific effects

    • Scrambled peptide controls for interaction studies

    • Mock-transfected or non-targeting siRNA controls for knockdown experiments

  • Positive Controls

    • Well-characterized membrane proteins of similar size and topology

    • Known interaction partners for binding studies

    • Established membrane protein functional assays with predictable outcomes

  • System Controls

    • Verification of membrane localization through fractionation studies

    • Confirmation of protein integrity via Western blot before functional assays

    • Validation of proper folding through activity of a co-expressed reporter domain

  • Validation Controls

    • Secondary independent assays to confirm primary findings

    • Dose-response relationships to establish specificity

    • Rescue experiments with wild-type protein in knockout/knockdown systems

Proper experimental control selection is crucial for distinguishing true biological effects from artifacts, particularly in membrane protein research where experimental challenges are numerous .

How can researchers develop activity assays for poorly characterized UPF0060 membrane proteins?

Developing functional assays for uncharacterized UPF0060 membrane proteins requires systematic approach:

Activity Assay Development Strategy:

  • Bioinformatic Prediction Approach

    • Use sequence analysis to identify conserved motifs suggesting function

    • Apply structural modeling to predict substrate binding sites

    • Explore genomic context for clues about functional pathways

    • Design initial assays based on predicted activities

  • Phenotypic Screening Method

    • Generate knockout or knockdown strains

    • Screen for altered sensitivity to various stresses (oxidative, osmotic, pH)

    • Measure changes in membrane potential or permeability

    • Assess growth under different nutrient limitations

  • Biochemical Activity Testing

    • Assay for common membrane protein functions (transport, enzymatic activity)

    • Screen against libraries of potential substrates

    • Measure binding to peptides, small molecules, or other proteins

    • Test for influence on membrane physical properties

  • In vivo Complementation

    • Express protein in heterologous systems with defined defects

    • Assess rescue of known phenotypes

    • Use chimeric proteins to identify functional domains

    • Perform domain swapping with characterized family members

This multifaceted approach increases the likelihood of identifying functional activities despite the current lack of characterized homologs with known functions.

What statistical considerations are important when analyzing data from UPF0060 membrane protein experiments?

Statistical analysis of UPF0060 membrane protein experimental data requires special considerations:

Statistical Analysis Recommendations:

  • Sample Size Determination

    • Power analyses should account for higher variability in membrane protein experiments

    • Typically require 1.5-2x more replicates than soluble protein studies

    • Minimum recommended: 6 biological replicates for key experiments

  • Data Transformation Approaches

    • Log transformation often needed for binding and activity data

    • Ratio-based normalization to control for membrane preparation variability

    • Careful selection of reference points for relative quantification

  • Variability Handling

    • Identify and account for sources of technical variability (protein preparation, lipid composition)

    • Mixed-effects models to separate biological from technical variation

    • Bootstrapping approaches for datasets with non-normal distributions

  • Multiple Testing Correction

    • Apply appropriate multiple testing corrections (Bonferroni, FDR)

    • Consider dependency structure between tests when using proteome-wide datasets

    • Report both corrected and uncorrected p-values with clear distinction

  • Reproducibility Considerations

    • Cross-validation between different experimental approaches

    • Blind analysis protocols for subjective measurements

    • Detailed reporting of all analytical parameters for reproducibility

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.